NASDAQ:BLCM Long Term Shareholder Notice: Investigation of Potential Wrongdoing at Bellicum Pharmaceuticals Inc
An investigation was announced forinvestors in shares of Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) concerning potential breaches of fiduciary duties by certain directors and officers of Bellicum Pharmaceuticals Inc.
View full press release